Loading...
LifeCycle Pharma Receives US Patent for its MeltDose Technology
18-May-2007
Advertisement
LifeCycle Pharma A/S announced the issuance of a patent for its MeltDose® Technology by the US Patent and Trademark Office, US Patent No. 7,217,431. The patent covers the method of making a particulate material containing a drug substance with low aqueous solubility, using a unique controlled agglomeration process. The issue of the MeltDose® patent does not change the company's financial expectations for 2007.